documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
285 rows where docket_id = "FDA-2016-N-2527" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-2527-8031 | FDA | None FDA-2016-N-2527 | Exhibit E-3 - Appendix B to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T15:02:42Z | 0 | 0 | 09000064828d2eb3 | |||
| FDA-2016-N-2527-8037 | FDA | None FDA-2016-N-2527 | Exhibit G-4 - Attachment 3 to Second Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-09-07T17:45:09Z | 0 | 0 | 09000064828d1da9 | |||
| FDA-2016-N-2527-8030 | FDA | None FDA-2016-N-2527 | Exhibit E-2 - Appendix A to Citizen Petion re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T14:23:15Z | 0 | 0 | 09000064828d2eb2 | |||
| FDA-2016-N-2527-8027 | FDA | None FDA-2016-N-2527 | Exhibit C - re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T13:48:47Z | 0 | 0 | 09000064828d2eaf | |||
| FDA-2016-N-2527-8029 | FDA | None FDA-2016-N-2527 | Exhibit E-1 - Citizen Petition dated July 28, 2011 re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T14:11:01Z | 0 | 0 | 09000064828d2eb1 | |||
| FDA-2016-N-2527-8026 | FDA | None FDA-2016-N-2527 | Exhibit B - re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T13:48:54Z | 0 | 0 | 09000064828d2eae | |||
| FDA-2016-N-2527-8033 | FDA | None FDA-2016-N-2527 | Exhibit F-2 - Appendix A to First Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T15:01:24Z | 0 | 0 | 09000064828d1da5 | |||
| FDA-2016-N-2527-8034 | FDA | None FDA-2016-N-2527 | Exhibit G-1 - Second Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T15:00:28Z | 0 | 0 | 09000064828d1da6 | |||
| FDA-2016-N-2527-8032 | FDA | None FDA-2016-N-2527 | Exhibit F-1 - First Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T15:01:54Z | 0 | 0 | 09000064828d2eb4 | |||
| FDA-2016-N-2527-8036 | FDA | None FDA-2016-N-2527 | Exhibit G-3 - Attachment 2 to Second Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T14:59:32Z | 0 | 0 | 09000064828d1da8 | |||
| FDA-2016-N-2527-8028 | FDA | None FDA-2016-N-2527 | Exhibit D - Analysis of NNN Proposed Rule re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T13:59:26Z | 0 | 0 | 09000064828d2eb0 | |||
| FDA-2016-N-2527-8035 | FDA | None FDA-2016-N-2527 | Exhibit G-2 - Attachment 1 to Second Supplement to Citizen Petition re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-09T04:00:00Z | 2017 | 8 | 2017-08-09T14:59:56Z | 0 | 0 | 09000064828d1da7 | |||
| FDA-2016-N-2527-8021 | FDA | None FDA-2016-N-2527 | Exhibit A - Reference List re Comment from RAI Services Company | Supporting & Related Material | Background Material | 2017-08-07T04:00:00Z | 2017 | 8 | 2017-08-07T19:01:38Z | 0 | 0 | 09000064828d2ead | |||
| FDA-2016-N-2527-2690 | FDA | None FDA-2016-N-2527 | PRIA Reference 39 - Establishment Registration & Tobacco Product Listing Sample | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:12Z | 0 | 0 | 0900006482605576 | |||
| FDA-2016-N-2527-2651 | FDA | None FDA-2016-N-2527 | PRIA Reference List (3) | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:23:46Z | 0 | 0 | 090000648260527e | |||
| FDA-2016-N-2527-2663 | FDA | None FDA-2016-N-2527 | PRIA Reference 12 - The Formation of Nitrosamines in Experimental Tobacco | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:26Z | 0 | 0 | 090000648260535f | |||
| FDA-2016-N-2527-2660 | FDA | None FDA-2016-N-2527 | PRIA Reference 9 - Are We Finally Winning the War on Cancer | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:13Z | 0 | 0 | 090000648260550f | |||
| FDA-2016-N-2527-2653 | FDA | None FDA-2016-N-2527 | PRIA Reference 2 - Statistical Report - Tobacco Report Symbol, 2015 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:49:44Z | 0 | 0 | 0900006482605508 | |||
| FDA-2016-N-2527-2655 | FDA | None FDA-2016-N-2527 | PRIA Reference 4 - National Vital Statistical Reports, 2015 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:49:51Z | 0 | 0 | 090000648260550a | |||
| FDA-2016-N-2527-2682 | FDA | None FDA-2016-N-2527 | PRIA Reference 31 - U.S. Business Administration | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:43Z | 0 | 0 | 090000648260556e | |||
| FDA-2016-N-2527-2664 | FDA | None FDA-2016-N-2527 | PRIA Reference 13 - Code Date Catalog | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:31Z | 0 | 0 | 0900006482605360 | |||
| FDA-2016-N-2527-2676 | FDA | None FDA-2016-N-2527 | PRIA Reference 25 - Topics for Biological and Biochemical Research | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:20Z | 0 | 0 | 0900006482605560 | |||
| FDA-2016-N-2527-2688 | FDA | None FDA-2016-N-2527 | PRIA Reference 37 - Occupation Employment Statistics | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:04Z | 0 | 0 | 0900006482605574 | |||
| FDA-2016-N-2527-2652 | FDA | None FDA-2016-N-2527 | PRIA Reference 1 - Combustible and Smokeless Tobacco Use | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:49:36Z | 0 | 0 | 0900006482605507 | |||
| FDA-2016-N-2527-2656 | FDA | None FDA-2016-N-2527 | PRIA Reference 5 - Smoking and Tobacco Use, 2014 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:49:54Z | 0 | 0 | 090000648260550b | |||
| FDA-2016-N-2527-2679 | FDA | None FDA-2016-N-2527 | PRIA Reference 28 - Patients Perceived Health Status Following Primary | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:30Z | 0 | 0 | 0900006482605563 | |||
| FDA-2016-N-2527-2685 | FDA | None FDA-2016-N-2527 | PRIA Reference 34 - Carcinogenic Tobacco Specific N-Nitrosamines in U.S | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:53Z | 0 | 0 | 0900006482605571 | |||
| FDA-2016-N-2527-2666 | FDA | None FDA-2016-N-2527 | PRIA Reference 15 - Literature Study N-Nitrosamines in Tobacco Products | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:40Z | 0 | 0 | 0900006482605362 | |||
| FDA-2016-N-2527-2671 | FDA | None FDA-2016-N-2527 | PRIA Reference 20 - SEER Cancer Statistics Review, 1975-2012 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:00Z | 0 | 0 | 0900006482605367 | |||
| FDA-2016-N-2527-2658 | FDA | None FDA-2016-N-2527 | PRIA Reference 7 - Raising th Excise Tax on Cigarettes Effects on Health and the Federal Budget, 2012 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:05Z | 0 | 0 | 090000648260550d | |||
| FDA-2016-N-2527-2680 | FDA | None FDA-2016-N-2527 | PRIA Reference 29 - Reformulation Cost Model FINAL REPORT | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:35Z | 0 | 0 | 0900006482605564 | |||
| FDA-2016-N-2527-2659 | FDA | None FDA-2016-N-2527 | PRIA Reference 8 - The 2015 Long Term Budget Outlook | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:09Z | 0 | 0 | 090000648260550e | |||
| FDA-2016-N-2527-2661 | FDA | None FDA-2016-N-2527 | PRIA Reference 10 - The Cost Effectiveness of Community Based Screening for Oral Cancer | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:18Z | 0 | 0 | 0900006482605510 | |||
| FDA-2016-N-2527-2675 | FDA | None FDA-2016-N-2527 | PRIA Reference 24 - Regional Convenience Store Markup Percentages | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:17Z | 0 | 0 | 090000648260555f | |||
| FDA-2016-N-2527-2683 | FDA | None FDA-2016-N-2527 | PRIA Reference 32 - Statistics of US Businesses 2013 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:46Z | 0 | 0 | 090000648260556f | |||
| FDA-2016-N-2527-2691 | FDA | None FDA-2016-N-2527 | PRIA Reference 40 - FDA's Electronic Reading Room - Warning Letters Sample | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:16Z | 0 | 0 | 0900006482605577 | |||
| FDA-2016-N-2527-2662 | FDA | None FDA-2016-N-2527 | PRIA Reference 11 - An Interim Determination of Health Gain from Oral Cancer | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:21Z | 0 | 0 | 090000648260535e | |||
| FDA-2016-N-2527-2669 | FDA | None FDA-2016-N-2527 | PRIA Reference 18 - Is Addiction Rational Theory and Evidence | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:53Z | 0 | 0 | 0900006482605365 | |||
| FDA-2016-N-2527-2654 | FDA | None FDA-2016-N-2527 | PRIA Reference 3 - Adjusting the Value of a Statistical Life | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:49:47Z | 0 | 0 | 0900006482605509 | |||
| FDA-2016-N-2527-2684 | FDA | None FDA-2016-N-2527 | PRIA Reference 33 - Tobacco-Specific Nitrosamines in New Tobacco Products | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:50Z | 0 | 0 | 0900006482605570 | |||
| FDA-2016-N-2527-2668 | FDA | None FDA-2016-N-2527 | PRIA Reference 17 - Tobacco and the Economy Farms, Jobs and | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:49Z | 0 | 0 | 0900006482605364 | |||
| FDA-2016-N-2527-2687 | FDA | None FDA-2016-N-2527 | PRIA Reference 36 - CPI Report 2015 Dec | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:00Z | 0 | 0 | 0900006482605573 | |||
| FDA-2016-N-2527-2692 | FDA | None FDA-2016-N-2527 | PRIA Reference 41 - Informing the NNN Product Standard RIA Memo | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:19Z | 0 | 0 | 090000648260558b | |||
| FDA-2016-N-2527-2665 | FDA | None FDA-2016-N-2527 | PRIA Reference 14 - Recurrence Rate and Shift in Histopathological Differentiation of | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:36Z | 0 | 0 | 0900006482605361 | |||
| FDA-2016-N-2527-2667 | FDA | None FDA-2016-N-2527 | PRIA Reference 16 - Prospective Investigation of the Cigarette Smoking | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:44Z | 0 | 0 | 0900006482605363 | |||
| FDA-2016-N-2527-2670 | FDA | None FDA-2016-N-2527 | PRIA Reference 19 - Report of Nationally Representative Values for the Non | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:56Z | 0 | 0 | 0900006482605366 | |||
| FDA-2016-N-2527-2657 | FDA | None FDA-2016-N-2527 | PRIA Reference 6 - Smoking and Tobacco Use, 2015 | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:50:02Z | 0 | 0 | 090000648260550c | |||
| FDA-2016-N-2527-2686 | FDA | None FDA-2016-N-2527 | PRIA Reference 35 - 50 Year Trends in Smoking Related Mortality in the U.S | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:57Z | 0 | 0 | 0900006482605572 | |||
| FDA-2016-N-2527-2689 | FDA | None FDA-2016-N-2527 | PRIA Reference 38 - Federal Trade Commission Smokeless Tobacco Product Report | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:08Z | 0 | 0 | 0900006482605575 | |||
| FDA-2016-N-2527-2677 | FDA | None FDA-2016-N-2527 | PRIA Reference 26 - The Determination of Tobacco Specific Nitrosamines in | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:24Z | 0 | 0 | 0900006482605561 | |||
| FDA-2016-N-2527-2678 | FDA | None FDA-2016-N-2527 | PRIA Reference 27 - Valuing Reductions in Fatal Illness Risks | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:27Z | 0 | 0 | 0900006482605562 | |||
| FDA-2016-N-2527-2681 | FDA | None FDA-2016-N-2527 | PRIA Reference 30 - FDA Labeling Cost Model FINAL | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:38Z | 0 | 0 | 0900006482605565 | |||
| FDA-2016-N-2527-2693 | FDA | None FDA-2016-N-2527 | PRIA Reference 42 - Crop Production 2014 Summary | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:52:23Z | 0 | 0 | 090000648260558c | |||
| FDA-2016-N-2527-2672 | FDA | None FDA-2016-N-2527 | PRIA Reference 21 - The Incentives Created by a Harm Reduction Approach | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:03Z | 0 | 0 | 090000648260555c | |||
| FDA-2016-N-2527-2673 | FDA | None FDA-2016-N-2527 | PRIA Reference 22 - Proposal for Basic Research on Tobacco Fermentation | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:07Z | 0 | 0 | 090000648260555d | |||
| FDA-2016-N-2527-2674 | FDA | None FDA-2016-N-2527 | PRIA Reference 23 - The Value of Health and Longevity | Supporting & Related Material | Background Material | 2017-05-23T04:00:00Z | 2017 | 5 | 2017-05-23T16:51:13Z | 0 | 0 | 090000648260555e | |||
| FDA-2016-N-2527-0259 | FDA | None FDA-2016-N-2527 | Letter from Robert Ellis to FDA | Other | Letter(s) | 2017-03-16T04:00:00Z | 2017 | 3 | 2017-03-16T04:00:00Z | 2017-03-16T16:19:44Z | 0 | 0 | 09000064825011b0 | ||
| FDA-2016-N-2527-0268 | FDA | None FDA-2016-N-2527 | Request to Extend Comment Period from RAI Services Company | Other | Request for Extension | 2017-03-16T04:00:00Z | 2017 | 3 | 2017-03-16T04:00:00Z | 2017-03-16T16:34:58Z | 0 | 0 | 0900006482509dbd | ||
| FDA-2016-N-2527-0269 | FDA | None FDA-2016-N-2527 | Request to Extend Comment Period from Reason Foundation | Other | Request for Extension | 2017-03-16T04:00:00Z | 2017 | 3 | 2017-03-16T04:00:00Z | 2017-03-16T16:35:11Z | 0 | 0 | 090000648250a4d0 | ||
| FDA-2016-N-2527-0255 | FDA | None FDA-2016-N-2527 | Letter from The Honorable Andy Barr to DHHS | Other | Letter(s) | 2017-03-16T04:00:00Z | 2017 | 3 | 2017-03-16T04:00:00Z | 2017-03-16T16:18:58Z | 0 | 0 | 09000064824f3b35 | ||
| FDA-2016-N-2527-0261 | FDA | None FDA-2016-N-2527 | Request to Extend Comment Period from Cheyenne International, LLC | Other | Request for Extension | 2017-03-16T04:00:00Z | 2017 | 3 | 2017-03-16T04:00:00Z | 2017-03-16T16:20:12Z | 0 | 0 | 0900006482504f00 | ||
| FDA-2016-N-2527-0226 | FDA | None FDA-2016-N-2527 | TAB B 2015-1102 Smokeless NNN Proposed Rule Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:49:58Z | 0 | 0 | 09000064824a3365 | |||
| FDA-2016-N-2527-0227 | FDA | None FDA-2016-N-2527 | TAB C 2015-1102 Smokeless NNN PRIA as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:50:06Z | 0 | 0 | 09000064824a3366 | |||
| FDA-2016-N-2527-0223 | FDA | None FDA-2016-N-2527 | TAB A 2015-1102 Smokeless NNN PRIA as Submitted to OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:49:33Z | 0 | 0 | 09000064824a3362 | |||
| FDA-2016-N-2527-0224 | FDA | None FDA-2016-N-2527 | TAB A 2015-1102 Smokeless NNN Proposed Rule as Submitted to OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:49:43Z | 0 | 0 | 09000064824a3363 | |||
| FDA-2016-N-2527-0222 | FDA | None FDA-2016-N-2527 | Memorandum to FDA DDM Tobacco Smokeless NNN Proposed Rule re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:49:25Z | 0 | 0 | 09000064824a3361 | |||
| FDA-2016-N-2527-0225 | FDA | None FDA-2016-N-2527 | TAB B 2015-1102 Smokeless NNN PRIA Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:49:51Z | 0 | 0 | 09000064824a3364 | |||
| FDA-2016-N-2527-0228 | FDA | None FDA-2016-N-2527 | TAB C 2015-1102 Smokeless NNN Proposed Rule as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-31T05:00:00Z | 2017 | 1 | 2017-02-07T14:50:13Z | 0 | 0 | 09000064824a3367 | |||
| FDA-2016-N-2527-0114 | FDA | None FDA-2016-N-2527 | Reference 107 - Hecht-2016-Exposure and Metabolic Activation B re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:46:36Z | 0 | 0 | 090000648248ec25 | |||
| FDA-2016-N-2527-0117 | FDA | None FDA-2016-N-2527 | Reference 110 - Stockwell, Impact of Smoking and Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:46:50Z | 0 | 0 | 090000648248ec28 | |||
| FDA-2016-N-2527-0121 | FDA | None FDA-2016-N-2527 | Reference 114 - Lee-2009-Systematic Review of the Relation Bet re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:47:09Z | 0 | 0 | 090000648248ec33 | |||
| FDA-2016-N-2527-0204 | FDA | None FDA-2016-N-2527 | Reference 198 - Mirvish, 1975, Formation of N-Nitroso Compounds re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:54:38Z | 0 | 0 | 090000648248ecd5 | |||
| FDA-2016-N-2527-0055 | FDA | None FDA-2016-N-2527 | Reference 48 - Morin, et al, Evolution of Tobacco Specific Ni re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:41:52Z | 0 | 0 | 090000648248ee8b | |||
| FDA-2016-N-2527-0092 | FDA | None FDA-2016-N-2527 | Reference 85 - Digard-2013-Multi-Analyte Approach for Determi re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:44:54Z | 0 | 0 | 090000648248eee3 | |||
| FDA-2016-N-2527-0129 | FDA | None FDA-2016-N-2527 | Reference 122 - Zhou-2013-Smokeless Tobacco and Risk of Head a re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:47:46Z | 0 | 0 | 090000648248f04c | |||
| FDA-2016-N-2527-0133 | FDA | None FDA-2016-N-2527 | Reference 126 - Yanovitzky-2000-Effect of Media Coverage and P re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:48:03Z | 0 | 0 | 090000648248f052 | |||
| FDA-2016-N-2527-0134 | FDA | None FDA-2016-N-2527 | Reference 127 - Cram-2003-The Impact of a Celebrity Promotiona re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:48:08Z | 0 | 0 | 090000648248f053 | |||
| FDA-2016-N-2527-0197 | FDA | None FDA-2016-N-2527 | Reference 191 - Boffetta, 2005, Smokeless Tobacco Use and Risk of Pancreatic Cancer re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:54:01Z | 0 | 0 | 090000648248f0da | |||
| FDA-2016-N-2527-0026 | FDA | None FDA-2016-N-2527 | Reference 19 - Foulds-2008-Is Low-Nicotine Marlboro Snus Real re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:39:29Z | 0 | 0 | 090000648248ede3 | |||
| FDA-2016-N-2527-0037 | FDA | None FDA-2016-N-2527 | Reference 30 - Brunnemann-1996-Formation and Analysis of Toba re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:40:24Z | 0 | 0 | 090000648248ee03 | |||
| FDA-2016-N-2527-0043 | FDA | None FDA-2016-N-2527 | Reference 36 - Burton-1994-Relationship Between Tobacco-Speci re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:40:51Z | 0 | 0 | 090000648248ee12 | |||
| FDA-2016-N-2527-0013 | FDA | None FDA-2016-N-2527 | Reference 6 - Song-2016-Chemical and Toxicological Character re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:38:26Z | 0 | 0 | 090000648248edc9 | |||
| FDA-2016-N-2527-0067 | FDA | None FDA-2016-N-2527 | Reference 60 - Hatsukami-1988-Topographical Features of Smoke re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:42:53Z | 0 | 0 | 090000648248eebf | |||
| FDA-2016-N-2527-0098 | FDA | None FDA-2016-N-2527 | Reference 91 - Brown, Patent US20050043515A1 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:45:22Z | 0 | 0 | 090000648248eeeb | |||
| FDA-2016-N-2527-0106 | FDA | None FDA-2016-N-2527 | Reference 99 - Stepanov, 2005, Tobacco Specific Nitrosamines and re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:45:58Z | 0 | 0 | 090000648248efd3 | |||
| FDA-2016-N-2527-0131 | FDA | None FDA-2016-N-2527 | Reference 124 - Chakravorty, B, Cessation Related Perceptions re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:47:54Z | 0 | 0 | 090000648248f04e | |||
| FDA-2016-N-2527-0145 | FDA | None FDA-2016-N-2527 | Reference 138 - Song-2009-Perceptions of Smoking-related Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:49:17Z | 0 | 0 | 090000648248f078 | |||
| FDA-2016-N-2527-0153 | FDA | None FDA-2016-N-2527 | Reference 147 - Hoffmann, 1990, Advances in Tobacco Carcinogenesis Chapt 3 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:49:58Z | 0 | 0 | 090000648248ec78 | |||
| FDA-2016-N-2527-0156 | FDA | None FDA-2016-N-2527 | Reference 150 - Prokopczyk, 1991, A Study of Betel Quid Carcinogenesis re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:50:13Z | 0 | 0 | 090000648248ec7d | |||
| FDA-2016-N-2527-0183 | FDA | None FDA-2016-N-2527 | Reference 177 - McIntee-2000-Metabolism of N'-nitrosonornicoti re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:52:53Z | 0 | 0 | 090000648248ecad | |||
| FDA-2016-N-2527-0196 | FDA | None FDA-2016-N-2527 | Reference 190 - Definition of cancer slope factor re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:53:56Z | 0 | 0 | 090000648248f0d7 | |||
| FDA-2016-N-2527-0212 | FDA | None FDA-2016-N-2527 | Reference 206 - Stepanov, et al, Tobacco specific Nitrosamines in Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:55:26Z | 0 | 0 | 090000648248f0f8 | |||
| FDA-2016-N-2527-0008 | FDA | None FDA-2016-N-2527 | Reference 1 - IARC, Monographs on the Evaluation of Carcinogenic Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:37:58Z | 0 | 0 | 090000648248ed71 | |||
| FDA-2016-N-2527-0078 | FDA | None FDA-2016-N-2527 | Reference 71 - Jitnarin-2015-Tobacco Use Pattern among a Nati re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:43:46Z | 0 | 0 | 090000648248ea81 | |||
| FDA-2016-N-2527-0079 | FDA | None FDA-2016-N-2527 | Reference 72 - Hecht, 2008, Exposure to Nicotine and Tobacco-specific re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:43:51Z | 0 | 0 | 090000648248ea82 | |||
| FDA-2016-N-2527-0111 | FDA | None FDA-2016-N-2527 | Reference 104 - Idris, 1995, Toombak Dipping and Cancer of the Oral Cavity re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:46:20Z | 0 | 0 | 090000648248ebd5 | |||
| FDA-2016-N-2527-0053 | FDA | None FDA-2016-N-2527 | Reference 46 - Staaf, Formation of Tobacco-specific Nitrosami re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:41:42Z | 0 | 0 | 090000648248ee89 | |||
| FDA-2016-N-2527-0064 | FDA | None FDA-2016-N-2527 | Reference 57 - EPA, Risk Assessment Guidance re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:42:39Z | 0 | 0 | 090000648248eeab | |||
| FDA-2016-N-2527-0105 | FDA | None FDA-2016-N-2527 | Reference 98 - Hecht, 2007, Similar Exposure to a Tobacco-sp re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:45:54Z | 0 | 0 | 090000648248efd2 | |||
| FDA-2016-N-2527-0130 | FDA | None FDA-2016-N-2527 | Reference 123 - Agaku, 2012, Evaluation of Factors Influencing re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products | Supporting & Related Material | Background Material | 2017-01-26T05:00:00Z | 2017 | 1 | 2017-01-26T22:47:50Z | 0 | 0 | 090000648248f04d |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;